Cargando…

Levels of soluble Fas/APO-1 in patients with Behçet's disease.

The aim of this study was to quantify soluble Fas/APO-1 (sFas/APO-1) protein in the serum of patients with Behcet's disease (BD) in active and inactive stages, compared with patients with systemic lupus erythematosus (SLE) and patients with rheumatoid arthritis (RA). Soluble Fas/APO-1 was quant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamzaoui, K, Hamzaoui, A, Zakraoui, L, Chabbou, A
Formato:	Texto
Lenguaje:	English
Publicado:	1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781828/ https://www.ncbi.nlm.nih.gov/pubmed/9836498

Ejemplares similares

Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
por: Hamzaoui, K, et al.
Publicado: (1999)

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis
por: Hamzaoui, A., et al.
Publicado: (1996)

Circulating intercellular adhesion molecules in blood and bronchoalveolar lavage in Behçet's disease
por: Hamzaoui, A., et al.
Publicado: (1995)

Interleukin-6 in peripheral blood and inflammatory sites in Behçet's disease
por: Hamzaoui, K., et al.
Publicado: (1992)

Lymphocytes apoptosis in patients with acute exacerbation of asthma.
por: Hamzaoui, A, et al.
Publicado: (1999)

Increased Endothelin-1 Levels of BAL Fluid in Patients with Behçet's Disease
por: Hamzaoui, Kamel, et al.
Publicado: (2007)

Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
por: Hamzaoui, Agnès, et al.
Publicado: (2003)

Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.
por: Houman, Habib, et al.
Publicado: (2004)

NOD2 is highly expressed in Behçet disease with pulmonary manifestations
por: Hamzaoui, Kamel, et al.
Publicado: (2012)

Pulmonary manifestations in Behçet disease: impaired natural killer cells activity
por: Hamzaoui, Kamel, et al.
Publicado: (2013)

Hyperhomocysteinaemia in Behçet's Disease
por: Hamzaoui, Amira, et al.
Publicado: (2010)

Expression of Th-17 and RORγt mRNA in Behçet’s Disease
por: Hamzaoui, Kamel, et al.
Publicado: (2011)

Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet disease with pulmonary involvement
por: Hamzaoui, Agnès, et al.
Publicado: (2010)

Elevation of serum soluble E-selectin and VCAM-1 in severe asthma.
por: Hamzaoui, A, et al.
Publicado: (2001)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome
por: Endo, S, et al.
Publicado: (1998)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

An unusual case of Behçet's disease presenting with postpartum ovarian iliac vein thrombosis and pulmonary embolism
por: Hammami, Sonia, et al.
Publicado: (2006)

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
Publicado: (1995)

Circulating soluble Fas levels and risk of ovarian cancer
por: Akhmedkhanov, Arslan, et al.
Publicado: (2003)

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005)

Inflammatory response in induced sputum mononuclear cells from patients with acute exacerbation of asthma.
por: Hamzaoui, A, et al.
Publicado: (2000)

Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
por: Sremec, Josip, et al.
Publicado: (2020)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Signaling through the Death Receptor CD95 (APO-1/FAS)
por: Peter, Marcus E.
Publicado: (2001)

An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis
por: Niino, Masaaki, et al.
Publicado: (2002)

T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma.
por: Hamzaoui, Agnès, et al.
Publicado: (2002)

APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases
por: Singh, Richa, et al.
Publicado: (2009)

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
Publicado: (1995)

Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL
por: Morello, Aurore, et al.
Publicado: (2013)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
por: Ikomey, George M, et al.
Publicado: (2012)

Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
por: Kim, Dae-Jun, et al.
Publicado: (2013)

Serum Levels of Soluble P-Selectin Are Increased and Associated With Disease Activity in Patients With Behçet's Syndrome
por: Turkoz, Yusuf, et al.
Publicado: (2005)

Inflammatory Process of CD8(+)CD28(−) T Cells in Induced Sputum From Asthmatic Patients
por: Hamzaoui, Agnes, et al.
Publicado: (2005)

Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
Publicado: (1994)

Regulatory T cells in induced sputum of asthmatic children: association with inflammatory cytokines
por: Hamzaoui, Agnès, et al.
Publicado: (2010)

Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
por: Kim, Wan-Uk, et al.
Publicado: (2007)

The Role of CTLA-4 Exon-1 49 A/G Polymorphism and Soluble CTLA-4 Protein Level in Egyptian Patients with Behçet's Disease
por: Abdel Galil, Sahar M., et al.
Publicado: (2014)

Link between vitamin D and airway remodeling
por: Berraies, Anissa, et al.
Publicado: (2014)

Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mqr4chh0s9ilrq121d2vgl0qm2